Investor Overview

Webcast ImageWebcast
Elan Corporation PLC Annual Shareholder Meeting (Live)
05/30/13 at 10:00 a.m. UKT
Elan Corporation PLC Annual Shareholder Meeting
Thursday, May 30, 2013 10:00 a.m. UKT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Company Overview:

 

Elan Corporation, plc is a biotechnology company, headquartered in Ireland, committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan was incorporated as a private limited company in Ireland in December 1969 and became a public limited company in January 1984. Elan shares trade on the New York and Irish Stock Exchanges.

What's New:

 
2012 Annual Report

Stock Quote:

 
ELN (ADS Common)
PriceChange% ChangeVolume
$12.47 + 0.110.89%19,008,470
Previous CloseToday's OpenIntraday HighIntraday Low
$12.36$12.38$12.55$12.36
05/24/13 4:04 p.m. ET
Minimum 20 minute delay

Recent Financial News:

More >>

 
23 May 2013
Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021
DUBLIN--(BUSINESS WIRE)--May. 23, 2013-- Elan Corporation, plc (“Elan”) (NYSE: ELN) today announced the pricing of the offering of US$850 million aggregate principal amount of 6.250% Senior Notes due 2021 (the “Notes”) by its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp. The Notes will be issued at par. The offering is expected to close on May 31, 2013, subject to customary closing conditions. The Notes will be ful... 
23 May 2013
Elan Corporation, plc' s Board of Directors Unanimously Reject Royalty Pharma' s Revised Tender Offer
DUBLIN--(BUSINESS WIRE)--May. 23, 2013-- Elan Corporation, plc (NYSE: ELN) (Elan) today announced that its Board of Directors, after careful review and consideration and with the assistance of its executive management team as well as outside financial and legal advisors, has determined that privately held investment firm Royalty Pharma's revised offer (“Royalty Pharma Offer") announced on Monday May 20, 2013 to acquire all of Elan's shares for $12.50 per... 
20 May 2013
Elan Announces Transactions: Decisively Transforming the Company
Proposed Transactions offer shareholders highly unique investment and asset proposition Acquisition of AOP Orphan – a private, orphan disease company headquartered in Vienna, Austria Acquires 48% of Newbridge Pharmaceuticals – a private Africa, Middle East & Turkey (AfMET) company, headquartered in Dubai, UAE AOP & Newbridge together reach 20%+ of the world’s growing population ... 
20 May 2013
Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021
DUBLIN--(BUSINESS WIRE)--May. 20, 2013-- Elan Corporation, plc (“Elan”) (NYSE: ELN) today announced that its wholly-owned subsidiaries, Elan Finance public limited company (“Elan Finance”) and Elan Finance Corp. (“Elan Corp.” and together with Elan Finance, the “Issuers”), intend to offer, subject to market conditions, US$800.0 million in aggregate principal amount of Senior Notes due 2021 (the “Notes”). The Notes will be fully and unconditionally guaran... 

Upcoming Events:

More >>

 
Elan Corporation PLC Annual Shareholder Meeting
Thursday, May 30, 2013 10:00 a.m. UKT
LocationThe Shelbourne Hotel
27 St. Stephen`s Green
DublinIE


Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Elan Corporation, PLC posts new information to the site. Just enter your e-mail address and click Submit.
 
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts Contact IR